| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/24/2002 | US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 01/24/2002 | US20020010550 Pharmacokinetic-based drug design tool and method |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010212 Assay for D-serine transport antagonist and use for treating psychosis |
| 01/24/2002 | US20020010143 Compositions and methods for the treatment of human cytomegalovirus infection |
| 01/24/2002 | US20020010125 Chemokinesis interferes with immune and inflammatory responses by increasing cell movements and altering cell migration patterns; interfere with spread of malignant cells through the body, and reduce inflammatory responses |
| 01/24/2002 | US20020009827 Microelectronic unit forming methods and materials |
| 01/24/2002 | US20020009796 Cell activity assay apparatus and methods for making and using same |
| 01/24/2002 | US20020009795 Deparaffinizing the sample, heating the sample in a chaotropic solution comprising a guanidinium compound to a temperature about 50-100 degree C. and time period 5-120 minute and recovring RNA, DNA, protein |
| 01/24/2002 | US20020009794 Isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009767 Frozen tissue microarrays and methods for using the same |
| 01/24/2002 | US20020009765 Evaluating microorganisms in solution; monitor microorganisms in sample, detect propagation of microorganisms in solution |
| 01/24/2002 | US20020009764 Antitumor agents for use in treatment of cancer |
| 01/24/2002 | US20020009763 Kit for evaluating glutamic-pyrivic transaminase activity; fo detecting cell damages or cytotoxicity in organs |
| 01/24/2002 | US20020009762 Assay for protein tyrosine phosphatases |
| 01/24/2002 | US20020009759 Detecting preferential cells in sample; obtain sample, mix with magnetic particles, incubate with label, analyze labeled cells |
| 01/24/2002 | US20020009758 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/24/2002 | US20020009757 Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity |
| 01/24/2002 | US20020009746 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids as well as use of said device |
| 01/24/2002 | US20020009745 Methods for detecting and classifying bladder cancer via human uroplakin genes |
| 01/24/2002 | US20020009743 That proliferate in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, where certain proportion of cells are committed to form neuronal cells, glial cells, or both; screening compounds |
| 01/24/2002 | US20020009742 Method and composition for the manufacture of molecular beacons |
| 01/24/2002 | US20020009740 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009738 Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such protein, in a sample; oligonucleotide hybridization and/or amplification to simultaneously detect two or more tissue-specific polynucleotides in a sample |
| 01/24/2002 | US20020009737 Kits employing oligonucleotide-binding e-tag probes |
| 01/24/2002 | US20020009736 Microarrays to screen regulatory genes |
| 01/24/2002 | US20020009735 Mammary gland chemokine |
| 01/24/2002 | US20020009734 Mutation in gene affects the ability of an individual to hydrolyze terminal glutamates from dietary folates; screening pregnant women for the increased risk of bearing children with neural tube defects |
| 01/24/2002 | US20020009733 Methods and compositions for modulating melting temperatures of nucleic acids |
| 01/24/2002 | US20020009731 Generating preferential nucleotide sequences; provide sample, mix with probes, recover nucleotide sequences not hybridized to probes |
| 01/24/2002 | US20020009730 Solid support; for use as a diagnostic tool in genetic analysis |
| 01/24/2002 | US20020009729 Methods for testing oligonucleotide arrays |
| 01/24/2002 | US20020009728 Target attached to a substrate is contacted with a sample suspected of comprising a probe polynucleotide such as aptamer under conditions in which the probe polynucleotide can bind to the target |
| 01/24/2002 | US20020009727 Detection of single nucleotide polymorphisms |
| 01/24/2002 | US20020009725 Identification |
| 01/24/2002 | US20020009723 Resonant bio-assay device and test system for detecting molecular binding events |
| 01/24/2002 | US20020009722 Stabilizing agents for preventing the degradation of nucleotide sequences during analysis |
| 01/24/2002 | US20020009721 Methods and formulations for the separation of biological macromolecul |
| 01/24/2002 | US20020009720 Plag gene family and tumorigenesis |
| 01/24/2002 | US20020009717 Methods for detecting, selecting and cloning agents that degrade or promote degradation of DNA |
| 01/24/2002 | US20020009716 Involves use of rolling circle amplification (RCA) coupled with primer extension and exonuclease deficient polymerases to detect single nucleotide polymorphism (STP); diagnosing genetic disorders |
| 01/24/2002 | US20020009714 Use of azetidinone compounds |
| 01/24/2002 | US20020009713 Detecting modulators of brain cell propagation; incubate neurons with modulator, measure amount of proteins or nucleotide sequences associated with preferential neurons, adjustment in amount of protein present indicates modulator |
| 01/24/2002 | US20020009712 Expression vector for use in the evaluation of gene expression in preferential cells; for monitoring tumor cell migration |
| 01/24/2002 | US20020009711 Detecting preferential cellular activty in sample; provide cells and binding particles, incubate, determine amount of binding within cells by measuring polarized fluorescent light in cell |
| 01/24/2002 | US20020009710 Random domain mapping |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009442 Diagnosis, therapy Aids |
| 01/24/2002 | US20020009438 Antimicrobial agents isolated from aloe vera |
| 01/24/2002 | US20020009435 Polypeptides having haloperoxidase activity |
| 01/24/2002 | US20020008030 Apparatus and method for performing microfluidic manipulations for chemical analysis |
| 01/24/2002 | DE10033583A1 Superparamagnetische Perlpolymerisate Superparamagnetic bead polymers |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/24/2002 | DE10033194A1 Biosonden und deren Verwendung Bioprobes and their use |
| 01/24/2002 | DE10032608A1 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte For microsatellite instability (MSI +) - related tumors genes and their gene |
| 01/24/2002 | DE10032568A1 Vorrichtung und Verfahren zum elektrischen Kontaktieren von in einer Flüssigkeit in Suspension befindlichen biologischen Zellen Apparatus and method for electrically contacting located in a liquid in suspension biological cells |
| 01/24/2002 | DE10032042A1 Elektrochemischer Einwegbiosensor für die quantitative Bestimmung von Analytkonzentrationen in Flüssigkeiten Electrochemical disposable biosensor for the quantitative determination of analyte concentrations in fluids |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | DE10030452A1 In vitro detection of DNA damage, useful e.g. for determining genotoxicity of chemicals, comprises measuring specific interaction between DNA and repair proteins |
| 01/24/2002 | DE10030376A1 Treating DNA with enzyme that alters sensitivity to exonuclease, useful e.g. for identifying therapeutic inhibitors of the enzyme |
| 01/24/2002 | CA2733852A1 Electrochemical method for measuring chemical reaction rates |
| 01/24/2002 | CA2697031A1 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2416744A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416559A1 Obesity associated biallelic marker maps |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416249A1 Antioxidant sensor |
| 01/24/2002 | CA2416248A1 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | CA2416179A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | CA2416091A1 Single primer pcr amplification of rna |
| 01/24/2002 | CA2416064A1 Glucose-1-phosphate thymidylyltransferase and method for selecting inhibitors thereof |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415731A1 A method for direct genetic analysis of target cells by using flourescence probes |
| 01/24/2002 | CA2415723A1 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2415342A1 Hemoglobin sensor |
| 01/24/2002 | CA2415328A1 Nested sorting and high throughput screening |
| 01/24/2002 | CA2415202A1 Extracellular matrix protein |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/24/2002 | CA2377664A1 Detection of copy number changes in colon cancer |
| 01/24/2002 | CA2352500A1 Nucleic acid, nucleic acid for detecting chlorinated ethylene-decomposing bacteria, probe, method of detecting chlorinated ethylene-decomposing bacteria, and method of decomposingchlorinated ethylene or ethane |
| 01/23/2002 | EP1174716A2 Recloseable biosensor |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174522A2 TCF-1 nucleotide sequence variation |
| 01/23/2002 | EP1174521A2 Method for detecting transcribed genomic DNA sequences |
| 01/23/2002 | EP1174520A2 Method for monitoring a fermentation process using an expression array |
| 01/23/2002 | EP1174519A2 Detection of nucleic acid amplification |
| 01/23/2002 | EP1174518A1 Collection of binding molecules |
| 01/23/2002 | EP1174517A2 Use of Very Long Chain Fatty Acid Elongase for the identification of herbicides |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174149A1 Proliferation inhibitor for androgen-independent tumor |
| 01/23/2002 | EP1173771A1 Procoagulant assay |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |